Thomas A. Satterfield, Jr. 13D and 13G filings for Coherus Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-04-29 9:02 pm Purchase | 2026-03-31 | 13G | COHERUS ONCOLOGY, INC. CHRS | Thomas A. Satterfield, Jr. | 6,930,000 4.600% | 920,486 (+15.32%) | Filing |
| 2025-04-16 5:37 pm Purchase | 2025-04-14 | 13G | COHERUS ONCOLOGY, INC. CHRS | Thomas A. Satterfield, Jr. | 6,009,514 5.200% | 6,009,514 (New Position) | Filing |